Target type: biologicalprocess
Any process that activates or increases the frequency, rate or extent of establishment or extent of a mitochondrial membrane potential, the electric potential existing across any mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane. [GOC:dph, GOC:tb]
Positive regulation of mitochondrial membrane potential is a crucial biological process that ensures proper mitochondrial function and cellular homeostasis. This process involves intricate molecular mechanisms that modulate the electrochemical gradient across the inner mitochondrial membrane, a vital component for energy production through oxidative phosphorylation. The maintenance of this membrane potential is crucial for several key cellular processes, including ATP synthesis, reactive oxygen species (ROS) production, and apoptosis.
The process of positive regulation of mitochondrial membrane potential can be influenced by various factors, including:
1. Electron Transport Chain (ETC): The ETC is the primary driver of mitochondrial membrane potential. It consists of a series of protein complexes embedded in the inner mitochondrial membrane that transfer electrons from NADH and FADH2 to oxygen. This electron transfer process generates a proton gradient across the membrane, with a higher concentration of protons in the intermembrane space than in the matrix. This proton gradient is the driving force for ATP synthesis by ATP synthase.
2. Proton Translocation: The movement of protons across the inner mitochondrial membrane is a key step in establishing and maintaining the membrane potential. Proton translocation is driven by the ETC and is facilitated by specific protein complexes that act as proton pumps. These pumps, including Complex I, III, and IV, utilize the energy released during electron transfer to move protons from the matrix to the intermembrane space.
3. Uncoupling Proteins (UCPs): These proteins are involved in regulating the membrane potential by dissipating the proton gradient. UCPs can allow protons to leak back across the membrane, reducing the proton gradient and consequently the membrane potential. While this may seem counterintuitive, UCPs play a crucial role in regulating energy expenditure and preventing oxidative stress.
4. Mitochondrial Respiration: The rate of mitochondrial respiration directly impacts the membrane potential. Increased respiration leads to higher electron flow through the ETC, generating a larger proton gradient and a more positive membrane potential. Conversely, decreased respiration results in a lower membrane potential.
5. Ca2+ Signaling: Calcium ions (Ca2+) play a significant role in regulating mitochondrial membrane potential. Elevated Ca2+ levels can stimulate mitochondrial respiration and enhance proton pumping by the ETC, leading to a more positive membrane potential. Conversely, decreased Ca2+ levels can reduce respiration and lower the membrane potential.
6. Reactive Oxygen Species (ROS): While ROS are often associated with oxidative stress, they also play a role in regulating mitochondrial function. Moderate levels of ROS can stimulate mitochondrial respiration and increase the membrane potential. However, excessive ROS production can damage mitochondrial components and disrupt the membrane potential, leading to cellular dysfunction.
7. Other Factors: Other factors, such as pH, temperature, and nutrient availability, can also influence the membrane potential. For instance, acidic pH can decrease membrane potential, while higher temperature can increase it.
The intricate interplay of these factors ensures that the mitochondrial membrane potential is maintained within a narrow range, allowing for optimal mitochondrial function and cellular homeostasis. Disruptions in this process can have severe consequences for cellular health and can contribute to various diseases, including neurodegenerative disorders, metabolic diseases, and cancer.'
"
Protein | Definition | Taxonomy |
---|---|---|
Bcl2-associated agonist of cell death | A Bcl2-associated agonist of cell death that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q92934] | Homo sapiens (human) |
BH3-interacting domain death agonist | A BH3-interacting domain death agonist that is encoded in the genome of human. [PRO:WCB, UniProtKB:P55957] | Homo sapiens (human) |
Transitional endoplasmic reticulum ATPase | A transitional endoplasmic reticulum ATPase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P55072] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
clotrimazole | conazole antifungal drug; imidazole antifungal drug; imidazoles; monochlorobenzenes | antiinfective agent; environmental contaminant; xenobiotic | |
gossypol | Gossypol: A dimeric sesquiterpene found in cottonseed (GOSSYPIUM). The (-) isomer is active as a male contraceptive (CONTRACEPTIVE AGENTS, MALE) whereas toxic symptoms are associated with the (+) isomer. | ||
sanguinarine | benzophenanthridine alkaloid : A specific group of isoquinoline alkaloids that occur only in higher plants and are constituents mainly of the Papaveraceae family. | alkaloid antibiotic; benzophenanthridine alkaloid; botanical anti-fungal agent | |
epigallocatechin gallate | (-)-epigallocatechin 3-gallate : A gallate ester obtained by the formal condensation of gallic acid with the (3R)-hydroxy group of (-)-epigallocatechin. epigallocatechin gallate: a steroid 5alpha-reductase inhibitor and antimutagen in green tea (Camellia sinensis) | flavans; gallate ester; polyphenol | antineoplastic agent; antioxidant; apoptosis inducer; geroprotector; Hsp90 inhibitor; neuroprotective agent; plant metabolite |
5,6,7,8-tetrahydro-1-naphthol | 5,6,7,8-tetrahydro-1-naphthol : 1-naphthol hydrogenated at C-5, -6, -7 and -8. | tetralins | |
chelerythrine chloride | |||
6-n-tridecylsalicylic acid | 6-n-tridecylsalicylic acid: structure given in first source | hydroxybenzoic acid | |
Methylenedioxycinnamic acid | hydroxycinnamic acid | ||
3,4-methylenedioxy-beta-nitrostyrene | 3,4-methylenedioxy-beta-nitrostyrene: tyrosine kinase inhibitor that prevents platelet glycoprotein IIb/IIIa activation; structure in first source | ||
4-(4-(4-chloro-phenyl)thiazol-2-ylamino)phenol | substituted aniline | ||
5,6-dehydrokawain | 5,6-dehydrokawain: from Alpinia speciosa rhizoma; RN given for cpd without isomeric designation; structure given in first source | 2-pyranones; aromatic ether | |
abt-737 | aromatic amine; aryl sulfide; biphenyls; C-nitro compound; monochlorobenzenes; N-arylpiperazine; N-sulfonylcarboxamide; secondary amino compound; tertiary amino compound | anti-allergic agent; anti-inflammatory agent; antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor | |
navitoclax | aryl sulfide; monochlorobenzenes; morpholines; N-sulfonylcarboxamide; organofluorine compound; piperazines; secondary amino compound; sulfone; tertiary amino compound | antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor | |
meiogynin a | meiogynin A: from the bark of Meiogyne cylindrocarpa; structure in first source | ||
ML240 | ML240 : A member of the class of quinazolines that is quinazoline which is substituted at positions 2, 5 and 8 by 2-amino-1H-benzimidazol-1-yl, benzylnitrilo and methoxy groups, respectively. It is a ATP-competetive inhibitor of AAA ATPase p97, also known as valosin-containing protein (VCP). | aromatic amine; aromatic ether; benzimidazoles; primary amino compound; quinazolines; secondary amino compound | antineoplastic agent |
abt-199 | venetoclax : A member of the class of pyrrolopyridines that is a potent inhibitor of the antiapoptotic protein B-cell lymphoma 2. It is used for treamtment of chronic lymphocytic leukemia with 17p deletion. venetoclax: A BCL-2 inhibitor with antineoplastic activity that is used in the treatment of CHRONIC LYMPHOCYTIC LEUKEMIA associated with chromosome 17p deletion; structure in first source. | aromatic ether; C-nitro compound; monochlorobenzenes; N-alkylpiperazine; N-arylpiperazine; N-sulfonylcarboxamide; oxanes; pyrrolopyridine | antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor |
ganciclovir | 2-aminopurines; oxopurine | antiinfective agent; antiviral drug | |
apogossypolone | apogossypolone: has antineoplastic activity; structure in first source |